Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.

Jobe, Dean A

Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease. [electronic resource] - Clinical and vaccine immunology : CVI Jun 2011 - 1034-7 p. digital

Publication Type: Journal Article

1556-679X

10.1128/CVI.00063-11 doi


Adult
Anti-Bacterial Agents--administration & dosage
Antibodies, Bacterial--blood
Antigens, Bacterial--immunology
Bacterial Outer Membrane Proteins--immunology
Blood Bactericidal Activity
Doxycycline--administration & dosage
Enzyme-Linked Immunosorbent Assay--methods
Humans
Immunoglobulin G--blood
Immunoglobulin M--blood
Lyme Disease--drug therapy
Oligopeptides
Time Factors